Month: February 2024

LegalZoom Expands Largest Grant Program To-Date to Deploy $3 Million to Small Business Owners as Part of Fast Break for Small Business Program With the NBA

Written by Customer Service on February 15, 2024. Posted in Public Companies.

NBA Champion and Two-time MVP Giannis Antetokounmpo and Two-time WNBA Champion Kelsey Plum team up with LegalZoom to support the small business community and share LegalZoom’s best plays for entrepreneursGiannis Antetokounmpo partners with LegalZoomNBA Champion and two-time MVP, Giannis Antetokounmpo partners with LegalZoom today to announce that applications are open for the annual Fast Break for Small Business grant program.MOUNTAIN VIEW, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — LegalZoom.com, Inc. (Nasdaq: LZ), the No. 1 choice in online small business formations, today announced that applications are open for the last round of the annual Fast Break for Small Business grant program in partnership with the NBA, WNBA and NBA G-League. This season will mark the program’s largest grant cohort to date with a campaign to...

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

Written by Customer Service on February 15, 2024. Posted in Earnings Releases And Operating Results.

SAN DIEGO, Feb. 15, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company will host a conference call and live audio webcast on Monday, February 26, 2024 at 5:00 PM ET to report its fourth quarter and full year 2023 financial results and provide a corporate update. In order to participate in the conference call, please register using the conference link here. The live webcast can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast...

Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2023

Written by Customer Service on February 15, 2024. Posted in Earnings Releases And Operating Results.

~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 9% to 11% sales growth in 2024 with expanding margins ~ PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023. Unless otherwise stated, all results and comparisons are from continuing operations. Fourth Quarter 2023 Financial Results (compared to fourth quarter 2022, except as noted)Sales increased 11% to $413 million. GAAP income from continuing operations increased $9 million to $26 million, an increase of 54%. Adjusted net income increased $10 million to $47 million, an increase of 28%. GAAP operating income increased $7 million to $44 million, an increase of 18%. Adjusted operating...

Where Food Comes From, Inc. Reports 2023 Fourth Quarter and Full Year Financial Results

Written by Customer Service on February 15, 2024. Posted in Earnings Releases And Operating Results.

Fourth Quarter Highlights – 2023 vs. 2022Verification and certification revenue up 17% to $5.5 million from $4.7 million Product sales flat at $0.9 million Total revenue up 10% to $6.7 million from $6.1 million Net income increased 58% to $776,000 from $490,000 Diluted EPS increased to $0.14 from $0.08 Adjusted EBITDA up 31% to $1.3 million from $1.0 million Company buys back more than $1.0 million of its stock in Q4Full-Year Highlights – 2023 vs. 2022Verification and certification revenue up 10% to $19.4 million from $17.6 million Product sales decline 8% to $4.0 million from $4.4 million Total revenue up slightly to $25.1 million from $24.8 million Net income increases 8% to $2.2 million from $2.0 million Diluted EPS of $0.39 vs. $0.33 Adjusted EBITDA flat at $3.8 million Cash generated from operations increased to $2.8 million...

Navios South American Logistics Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2023

Written by Customer Service on February 15, 2024. Posted in Earnings Releases And Operating Results.

Revenue$85.3 million in Q4 2023 $310.8 million in FY 2023Profit$3.2 million in Q4 2023 $13.8 million in FY 2023Adjusted EBITDA, a Non-IFRS measure$35.2 million in Q4 2023 $123.8 million in FY 2023MONTEVIDEO, Uruguay, Feb. 15, 2024 (GLOBE NEWSWIRE) — Navios South American Logistics Inc. (“Navios Logistics” or the “Company”), one of the largest infrastructure and logistics companies in the Hidrovia region of South America, today reported its financial results for the fourth quarter and year ended December 31, 2023. Angeliki Frangou, Chairwoman, stated “We are pleased with the results for 2023. Our adjusted EBITDA increased by 30% compared to 2022. The region continues to grow at a healthy pace, and all of our segments are expected to continue to perform well. For 2024, about 75% of our dry barge convoys’...

Global Rehabilitation Equipment Market to Surpass 24.28 Billion by 2030 Driven by Expanding Emphasis on Home Healthcare

Written by Customer Service on February 15, 2024. Posted in Mergers And Acquisitions.

SkyQuest projects that the global rehabilitation equipment market will attain a value of USD24.28 billion by 2030, with a CAGR of 6.1% during the forecast period (2023-2030). The global rehabilitation equipment market is witnessing substantial growth, driven by various compelling factors. Rehabilitation equipment encompasses multiple devices and tools designed to support individuals in their physical recovery journey, ultimately enhancing their quality of life following an illness, injury, or surgical procedure. Westford,USA, Feb. 15, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the global rehabilitation equipment market is currently presented with a significant opportunity for growth due to the expanding emphasis on home healthcare and telehealth services. This trend has paved the way for development of portable and user-friendly...

Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update

Written by Customer Service on February 15, 2024. Posted in Public Companies.

WARMINSTER, Pa., Feb. 15, 2024 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it has scheduled its fourth quarter and year end 2023 financial results and corporate update for Thursday, February 29, 2024. The schedule for the press release and conference call/webcast are as follows:• Q4 and Year End 2023 Press Release: Thursday, February 29, 2024 at 7:30 a.m. ET• Q4 and Year End 2023 Conference Call/Webcast: Thursday, February 29, 2024 at 8:45 a.m. ETTo dial-in for the conference call by phone, please register using the following link: Registration Link. A live webcast of the conference call can be accessed through...

Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman

Written by Customer Service on February 15, 2024. Posted in Public Companies.

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) — Evome Medical Technologies Inc. (the “Company” or “Evome”) announces the appointment of two senior healthcare executives to its Board of Directors.‎ Mr. Wayne Anderson, former President and CEO of Ferring Pharmaceuticals USA, has joined as a non-executive ‎member of the Board of Directors.‎ Mr. Bill Garbarini, a former Ferring Pharmaceuticals USA executive and current COO of Conceivable Life Sciences, a venture backed in-vitro fertilization company, will also join as a non-executive member of the Board of Directors. In addition, Kenneth Kashkin, MD, has been appointed Chairman of the Board of Directors. Dr. Kashkin is Board Certified in Internal Medicine, Neurology & Psychiatry with training at, and serving on, the faculties of the University of California, Los Angeles (UCLA) and...

Bread Financial Provides Performance Update for January 2024

Written by Customer Service on February 15, 2024. Posted in Earnings Releases And Operating Results.

COLUMBUS, Ohio, Feb. 15, 2024 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions, provided a performance update. The following tables present the Company’s net loss rate and delinquency rate for the periods indicated. For themonth endedJanuary 31, 2024 For themonth endedJanuary 31, 2023 (dollars in millions)End-of-period credit card and other loans $ 18,785 $ 20,837 Average credit card and other loans (1) $ 18,915 $ 20,700 Year-over-year change in average credit card and other loans (9 %) 23 %Net principal losses (1)(2) $ 128 $ 115 Net loss rate (1)(2) 8.0 % 6.7 % As ofJanuary 31, 2024 As ofJanuary 31, 2023 (dollars in millions)30...

Kelly Reports Fourth-Quarter 2023 Earnings

Written by Customer Service on February 15, 2024. Posted in Earnings Releases And Operating Results.

Q4 operating earnings of $7.3 million, or up 59% to $22.1 million on an adjusted basis Q4 revenue was flat; down 1.3% in constant currency Q4 adjusted EBITDA margin increased 60 basis points to 2.6% driven by meaningful reduction in operating expenses resulting from business transformation initiatives Company expects Q1 2024 sale of European staffing operations, sustained structural expense reductions and near-term outcome from growth initiatives to drive further expansion of EBITDA marginTROY, Mich., Feb. 15, 2024 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the fourth quarter of 2023. Peter Quigley, president and chief executive officer, announced revenue for the fourth quarter of 2023 totaled $1.2 billion, a 0.1% decrease, or a 1.3% decrease in...

Month: February 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals